102 related articles for article (PubMed ID: 10668707)
1. Gender differences in the treatment of behavior problems in Alzheimer's disease. SAGE Study Group. Systemic Assessment of Geriatric drug use via Epidemiology.
Ott BR; Lapane KL; Gambassi G
Neurology; 2000 Jan; 54(2):427-32. PubMed ID: 10668707
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. SAGE Study Group. Systematic Assessment and Geriatric drug use via Epidemiology.
Fernandez HH; Lapane KL; Ott BR; Friedman JH
Mov Disord; 2000 May; 15(3):490-6. PubMed ID: 10830414
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in the frequency and treatment of behavior problems in Parkinson's disease.
Fernandez HH; Lapane KL; Ott BR; Friedman JH
Mov Disord; 2000 May; 15(3):490-496. PubMed ID: 28470738
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group.
Gambassi G; Lapane KL; Landi F; Sgadari A; Mor V; Bernabie R
Neurology; 1999 Aug; 53(3):508-16. PubMed ID: 10449112
[TBL] [Abstract][Full Text] [Related]
5. Correlates and management of nonmalignant pain in the nursing home. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
Won A; Lapane K; Gambassi G; Bernabei R; Mor V; Lipsitz LA
J Am Geriatr Soc; 1999 Aug; 47(8):936-42. PubMed ID: 10443853
[TBL] [Abstract][Full Text] [Related]
6. Tacrine use in nursing homes: implications for prescribing new cholinesterase inhibitors. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology.
Gifford DR; Lapane KL; Gambassi G; Landi F; Mor V; Bernabei R
Neurology; 1999 Jan; 52(2):238-44. PubMed ID: 9932937
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Cholinesterase Inhibitors with or without Memantine on Antipsychotic Prescribing.
Blaszczyk AT; Mang BH; Garza H; Mathys M
Consult Pharm; 2018 May; 33(5):273-282. PubMed ID: 29789049
[TBL] [Abstract][Full Text] [Related]
8. Clinical, behavioral, and treatment differences in nursing facility residents with dementia, with and without pseudobulbar affect symptomatology.
Zarowitz BJ; O'Shea T
Consult Pharm; 2013 Nov; 28(11):713-22. PubMed ID: 24217191
[TBL] [Abstract][Full Text] [Related]
9. Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care.
Lövheim H; Sandman PO; Kallin K; Karlsson S; Gustafson Y
Int Psychogeriatr; 2006 Dec; 18(4):713-26. PubMed ID: 16879762
[TBL] [Abstract][Full Text] [Related]
10. Analyses of gender differences in profiles of nursing home residents with Alzheimer's disease.
Buchanan RJ; Wang S; Ju H; Graber D
Gend Med; 2004 Aug; 1(1):48-59. PubMed ID: 16115583
[TBL] [Abstract][Full Text] [Related]
11. Modifiable factors related to abusive behaviors in nursing home residents with dementia.
Volicer L; Van der Steen JT; Frijters DH
J Am Med Dir Assoc; 2009 Nov; 10(9):617-22. PubMed ID: 19883883
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.
Moga DC; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Wu Q; Jicha GA; Gnjidic D
Drugs Aging; 2017 Jan; 34(1):55-65. PubMed ID: 27896799
[TBL] [Abstract][Full Text] [Related]
13. Undertreatment of osteoporosis in residents of nursing homes: population-based study with use of the Systematic Assessment of Geriatric Drug Use via Epidemiology (SAGE) database.
Rojas-Fernandez CH; Lapane KL; MacKnight C; Howard KA
Endocr Pract; 2002; 8(5):335-42. PubMed ID: 15259120
[TBL] [Abstract][Full Text] [Related]
14. An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses.
Phillips LJ; Birtley NM; Petroski GF; Siem C; Rantz M
J Psychiatr Ment Health Nurs; 2018 Oct; 25(8):463-474. PubMed ID: 29911331
[TBL] [Abstract][Full Text] [Related]
15. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
16. Prescribing pattern of psychotropic drugs in nursing home residents with dementia.
Wetzels RB; Zuidema SU; de Jonghe JF; Verhey FR; Koopmans RT
Int Psychogeriatr; 2011 Oct; 23(8):1249-59. PubMed ID: 21682938
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic drug use among nursing home residents taking rivastigmine.
Narayanan S; Beusterien KM; Thomas SK; Musher J; Strunk B
J Am Med Dir Assoc; 2006 Jan; 7(1):12-6. PubMed ID: 16413429
[TBL] [Abstract][Full Text] [Related]
18. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study.
Laitinen ML; Lönnroos E; Bell JS; Lavikainen P; Sulkava R; Hartikainen S
Int Psychogeriatr; 2015 Apr; 27(4):669-72. PubMed ID: 25412711
[TBL] [Abstract][Full Text] [Related]
19. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
Mamun K; Goh-Tan CY; Ng LL
Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
[TBL] [Abstract][Full Text] [Related]
20. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC
Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
